Bridgewater Associates LP cut its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 68.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 5,088 shares of the medical equipment provider’s stock after selling 11,208 shares during the period. Bridgewater Associates LP’s holdings in Integer were worth $661,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently bought and sold shares of ITGR. Contravisory Investment Management Inc. raised its stake in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares in the last quarter. Huntington National Bank lifted its holdings in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. Quest Partners LLC boosted its position in shares of Integer by 3,688.9% during the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 142 shares during the period. Finally, Innealta Capital LLC purchased a new position in shares of Integer in the 2nd quarter valued at about $110,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
ITGR has been the topic of several recent analyst reports. Benchmark upped their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. KeyCorp raised their price objective on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Truist Financial decreased their target price on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Citigroup upped their target price on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. Finally, Bank of America lifted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Integer presently has an average rating of “Moderate Buy” and an average price target of $139.75.
Integer Trading Down 1.3 %
Shares of ITGR opened at $138.74 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer Holdings Co. has a 12 month low of $86.42 and a 12 month high of $142.00. The stock has a market cap of $4.65 billion, a PE ratio of 42.82, a P/E/G ratio of 2.01 and a beta of 1.09. The stock’s 50-day moving average is $131.59 and its two-hundred day moving average is $124.64.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.27 EPS. Equities analysts forecast that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
- Five stocks we like better than Integer
- Stock Market Sectors: What Are They and How Many Are There?
- How to Master Trading Discipline: Overcome Emotional Challenges
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.